238 related articles for article (PubMed ID: 20574122)
1. Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.
Mousavi T; Poormoghim H; Moradi M; Tajik N; Shahsavar F; Asadifar B
Iran J Immunol; 2010 Jun; 7(2):88-95. PubMed ID: 20574122
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.
Naumova E; Mihaylova A; Stoitchkov K; Ivanova M; Quin L; Toneva M
Cancer Immunol Immunother; 2005 Feb; 54(2):172-8. PubMed ID: 15248031
[TBL] [Abstract][Full Text] [Related]
3. KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.
Tajik N; Shahsavar F; Poormoghim H; Radjabzadeh MF; Mousavi T; Jalali A
Int J Immunogenet; 2011 Oct; 38(5):403-9. PubMed ID: 21797986
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.
Gao X; Jiao Y; Wang L; Liu X; Sun W; Cui B; Chen Z; Zhao Y
Clin Immunol; 2010 Oct; 137(1):139-46. PubMed ID: 20643584
[TBL] [Abstract][Full Text] [Related]
5. Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis.
Díaz-Peña R; Vidal-Castiñeira JR; Alonso-Arias R; Suarez-Alvarez B; Vicario JL; Solana R; Collantes E; López-Vázquez A; Martínez-Borra J; López-Larrea C
Arthritis Rheum; 2010 Apr; 62(4):1000-6. PubMed ID: 20131260
[TBL] [Abstract][Full Text] [Related]
6. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.
Lorentzen AR; Karlsen TH; Olsson M; Smestad C; Mero IL; Woldseth B; Sun JY; Senitzer D; Celius EG; Thorsby E; Spurkland A; Lie BA; Harbo HF
Ann Neurol; 2009 Jun; 65(6):658-66. PubMed ID: 19630074
[TBL] [Abstract][Full Text] [Related]
7. Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.
Jobim M; Chagastelles P; Salim PH; Portela P; Wilson TJ; Curti AG; Jobim MR; João DA; Nardi NB; Tschiedel B; Jobim LF; Roesler R; Schwartsmann G
Hum Immunol; 2010 Aug; 71(8):799-803. PubMed ID: 20580654
[TBL] [Abstract][Full Text] [Related]
8. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
[TBL] [Abstract][Full Text] [Related]
9. Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis.
Karlsen TH; Boberg KM; Olsson M; Sun JY; Senitzer D; Bergquist A; Schrumpf E; Thorsby E; Lie BA
J Hepatol; 2007 May; 46(5):899-906. PubMed ID: 17383044
[TBL] [Abstract][Full Text] [Related]
10. Impact of "Killer Immunoglobulin-Like Receptor /Ligand" Genotypes on Outcome following Surgery among Patients with Colorectal Cancer: Activating KIRs Are Associated with Long-Term Disease Free Survival.
Beksac K; Beksac M; Dalva K; Karaagaoglu E; Tirnaksiz MB
PLoS One; 2015; 10(7):e0132526. PubMed ID: 26181663
[TBL] [Abstract][Full Text] [Related]
11. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
Bakker AB; Phillips JH; Figdor CG; Lanier LL
J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
[TBL] [Abstract][Full Text] [Related]
12. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
[TBL] [Abstract][Full Text] [Related]
13. Distribution of the killer cell immunoglobulin-like receptors in Mexican Mestizos.
Contreras G; Aláez C; Murguía A; García D; Flores H; Gorodezky C
Tissue Antigens; 2007 Apr; 69 Suppl 1():125-9. PubMed ID: 17445185
[TBL] [Abstract][Full Text] [Related]
14. Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
Littera R; Chessa L; Onali S; Figorilli F; Lai S; Secci L; La Nasa G; Caocci G; Arras M; Melis M; Cappellini S; Balestrieri C; Serra G; Conti M; Zolfino T; Casale M; Casu S; Pasetto MC; Barca L; Salustro C; Matta L; Scioscia R; Zamboni F; Faa G; Orrù S; Carcassi C
PLoS One; 2016; 11(1):e0146086. PubMed ID: 26744892
[TBL] [Abstract][Full Text] [Related]
15. Killer immunoglobulin-like receptors (KIR) and their HLA-ligands in Italian paroxysmal nocturnal haemoglobinuria (PNH) patients.
Cosentini E; Gargiulo L; Bruno P; Lastraioli S; Risitano A; Camerlingo R; Luongo V; Serra M; Sica M; Garzillo C; Giani U; Notaro R; Alfinito F; Ruggiero G; Terrazzano G
Tissue Antigens; 2012 Oct; 80(4):322-7. PubMed ID: 22803950
[TBL] [Abstract][Full Text] [Related]
16. KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation.
Littera R; Piredda G; Argiolas D; Lai S; Congeddu E; Ragatzu P; Melis M; Carta E; Michittu MB; Valentini D; Cappai L; Porcella R; Alba F; Serra M; Loi V; Maddi R; Orrù S; La Nasa G; Caocci G; Cusano R; Arras M; Frongia M; Pani A; Carcassi C
PLoS One; 2017; 12(7):e0180831. PubMed ID: 28686681
[TBL] [Abstract][Full Text] [Related]
17. Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis.
Harvey D; Pointon JJ; Sleator C; Meenagh A; Farrar C; Sun JY; Senitzer D; Middleton D; Brown MA; Wordsworth BP
Ann Rheum Dis; 2009 Apr; 68(4):595-8. PubMed ID: 19019897
[TBL] [Abstract][Full Text] [Related]
18. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.
Winter CC; Gumperz JE; Parham P; Long EO; Wagtmann N
J Immunol; 1998 Jul; 161(2):571-7. PubMed ID: 9670929
[TBL] [Abstract][Full Text] [Related]
19. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
Guo KY; Mei JZ; Yao KT
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
[TBL] [Abstract][Full Text] [Related]
20. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals.
Foley B; De Santis D; Lathbury L; Christiansen F; Witt C
Int Immunol; 2008 Apr; 20(4):555-63. PubMed ID: 18308713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
